Literature DB >> 19952401

[Expression of FGF-2 and osteopontin in non-small cell lung cancer].

Ting Li1, Jianhua Zhou, Zhenghao Deng, Chunyan Fu, Haiying Jiang, Zhenqin Gao, Jinsheng Wang, Hongzheng Ren, Peng Wang.   

Abstract

OBJECTIVE: To investigate the expression of fibroblast growth factor-2 (FGF-2) and osteopontin (OPN) in non-small cell lung cancer (NSCLC) tissues and analyze the correlation between FGF-2 and OPN.
METHODS: Immunohistochemical SP method was used to detect the expression of FGF-2 and OPN in 76 patients with NSCLC and 15 normal lung tissues. The effect of FGF-2 on OPN expression at mRNA and protein level in A549 cell was examined by RT-PCR and Western blot.
RESULTS: The positive expression of FGF-2 (65.8%) and OPN (60.5%) in the NSCLC tissues was significantly higher than that in the normal lung tissues (13.3% and 0, respectively ) (P<0.01). The expression of FGF-2 and OPN was closely related to TNM stages and the lymph node metastasis (all Ps<0.01), but not to histological types, sex, and age of NSCLC patients (all Ps>0.05).A positive correlation was found between the expression of FGF-2 and OPN in NSCLC (r=0.552,P<0.01). The expression of OPN protein and mRNA was up-regulated by FGF-2 in A549 cells.
CONCLUSION: The overexpression of FGF-2 and OPN is related to the metastasis and invasion of NSCLC.FGF-2 may promote the metastasis and invasion of NSCLC depending on the upregulation of OPN expression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19952401

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  2 in total

1.  The prognostic value of osteopontin expression in non-small cell lung cancer: a meta-analysis.

Authors:  Tao Zhang; Dong-Ming Zhang; Da Zhao; Xiao-Ming Hou; Xiao-Jun Liu; Xiao-Ling Ling; Shou-Cheng Ma
Journal:  J Mol Histol       Date:  2014-05-10       Impact factor: 2.611

2.  Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer.

Authors:  Xiaoping Ouyang; Yumin Huang; Xing Jin; Wei Zhao; Tao Hu; Feng Wu; Jianan Huang
Journal:  Onco Targets Ther       Date:  2018-09-19       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.